New heartbeam patent for 12-lead electrocardiogram (ecg) smartwatch-based monitor intended for detection of heart attacks and complex cardiac arrhythmias

Santa clara, calif.--( business wire )--heartbeam, inc. (nasdaq: beat), a cardiac technology company that has developed the first and only 3d-vector electrocardiogram (vecg) platform for heart attack detection anytime, anywhere, announced today that its patent for a 12-lead electrocardiogram (ecg) smartwatch-based monitor intended for detection of heart attacks and complex cardiac arrhythmias was allowed by the united states patent and trademark office. the innovation builds on heartbeam's growing intellectual property portfolio enabling 12-lead ecg diagnostics outside of a medical setting.
BEAT Ratings Summary
BEAT Quant Ranking